Conclusions
More than one third of patients in BALKAN-AF received a rhythm control strategy, and these patients tended to be younger with less comorbidities than those managed with rate control. EHRA symptom score is not significantly associated with rhythm control. The most commonly used antiarrhythmic agents were amiodarone, followed by propafenone.